Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation

Infection

Volumn 42, Issue 2, 2014, Pages 445-447

  Wolf, T ^a   Kiderlen, T ^a   Atta, J ^a   Stephan, C ^a   Kann, G ^a   Brodt, H R ^a   Brandts, C ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CARMUSTINE; CD20 ANTIGEN; COTRIMOXAZOLE; CYTARABINE; DARUNAVIR PLUS RITONAVIR; DOXORUBICIN; EMTRICITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; METHOTREXATE; RALTEGRAVIR; RITUXIMAB; TENOFOVIR; THIOTEPA; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APHASIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD TOXICITY; BONE MARROW BIOPSY; BRAIN BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; DISEASE ASSOCIATION; DRUG MEGADOSE; EPSTEIN BARR VIRUS; ERYTHROCYTE TRANSFUSION; GRAFT FAILURE; HEMATOPOIETIC STEM CELL; HERPES LABIALIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; JC VIRUS; KAPOSI SARCOMA; LARGE CELL LYMPHOMA; MALE; NEUTROPENIA; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PARESIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; REMISSION; THROMBOCYTE TRANSFUSION; TONIC CLONIC SEIZURE; TOXOPLASMOSIS; AUTOTRANSPLANTATION; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMPLICATION; EPSTEIN-BARR VIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ISOLATION AND PURIFICATION; LYMPHOMA, NON-HODGKIN; TREATMENT OUTCOME; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM NEOPLASMS; EPSTEIN-BARR VIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84897536186     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0579-8     Document Type: Article

References (4)

1. Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, Plettenberg A, Buhk T, Stellbrink HJ, Horst HA, Jäger H, Rosenkranz T. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS. 2001;15:2119-27.
2. Wolf T, Brodt HR, Fichtlscherer S, Mantzsch K, Hoelzer D, Helm EB, Mitrou PS, Chow KU. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma. 2005;46:207-15.
3. Illerhaus G, Marks R, Ihorst G, Guttenberger R, Ostertag C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma. J Clin Oncol. 2006;24:3865-70.
4. Illerhaus G, Müller F, Feuerhake F, Schäfer AO, Ostertag C, Finke J. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system. Haematologica. 2008;93:147-8.